GLIVEC 400 MG COM REV CT BL AL AL X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1006801740090
  • GGREM 526523020100903
  • Código de barras 7896261022454
  • Código de barras 7896261024144

O que a fonte publica

Detentor do registro
NOVARTIS BIOCIENCIAS S.A
Princípios ativos
MESILATO DE IMATINIBE
Embalagem
400 MG COM REV CT BL AL AL X 30
Regime de dispensação
Tarja Vermelha
Tipo de produto
Novo
Classe terapêutica
L1H1 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BCR-ABL
Prescrição
Sob prescrição ou restrito

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:526523020100903
{
  "name": "GLIVEC 400 MG COM REV CT BL AL AL X 30",
  "holder": "NOVARTIS BIOCIENCIAS S.A",
  "stripe": "Tarja Vermelha",
  "barcodes": [
    "7896261022454",
    "7896261024144"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "526523020100903",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": true,
  "holderTaxId": "56.994.502/0001-30",
  "priceRegime": "Regulado",
  "productName": "GLIVEC",
  "productType": "Novo",
  "hospitalOnly": false,
  "presentation": "400 MG COM REV CT BL AL AL X 30",
  "sourceStatus": null,
  "supplyRegime": "Tarja Vermelha",
  "factoryPrices": {
    "icms-0": "17844.85",
    "icms-12": "20278.25",
    "icms-17": "21499.81",
    "icms-18": "21762.01",
    "icms-19": "22030.68",
    "icms-20": "22306.06",
    "icms-21": "22588.42",
    "icms-22": "22878.01",
    "icms-23": "23175.12",
    "icms-17.5": "21630.12",
    "icms-19.5": "22167.52",
    "icms-20.5": "22446.36",
    "icms-22.5": "23025.62",
    "icms-12-alc": "20034.89",
    "icms-17-alc": "21241.81",
    "icms-18-alc": "21500.87",
    "icms-19-alc": "21766.31",
    "icms-20-alc": "22038.37",
    "icms-21-alc": "22317.36",
    "icms-22-alc": "22603.46",
    "icms-23-alc": "22897.01",
    "withoutTaxes": "17630.71",
    "icms-17.5-alc": "21370.55",
    "icms-19.5-alc": "21901.50",
    "icms-20.5-alc": "22176.99",
    "icms-22.5-alc": "22749.31"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "MESILATO DE IMATINIBE",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "24597.27",
    "icms-12": "27951.46",
    "icms-17": "29635.25",
    "icms-18": "29996.66",
    "icms-19": "30367.00",
    "icms-20": "30746.58",
    "icms-21": "31135.78",
    "icms-22": "31534.95",
    "icms-23": "31944.49",
    "icms-17.5": "29814.87",
    "icms-19.5": "30555.62",
    "icms-20.5": "30939.97",
    "icms-22.5": "31738.42",
    "icms-12-alc": "27697.06",
    "icms-17-alc": "29365.56",
    "icms-18-alc": "29723.69",
    "icms-19-alc": "30090.65",
    "icms-20-alc": "30466.75",
    "icms-21-alc": "30852.44",
    "icms-22-alc": "31247.96",
    "icms-23-alc": "31653.77",
    "withoutTaxes": "24373.42",
    "icms-17.5-alc": "29543.53",
    "icms-19.5-alc": "30277.54",
    "icms-20.5-alc": "30658.39",
    "icms-22.5-alc": "31449.59"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "MESILATO DE IMATINIBE"
  ],
  "therapeuticClass": "L1H1 - INIBIDORES PREOTEÍNA KINASE ANTINEOPLÁSICOS, BCR-ABL",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1006801740090",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "prescription-or-restricted",
  "prescriptionRequired": true,
  "therapeuticClassCode": "L1H1",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:526523020100903"